<unk>  may occur in asthma patients being treated with<unk><unk><unk> s, occurring 2 days to 10 months after the<unk>  has been started, with features of the<unk>  including peripheral eosinophilia, pulmonary infiltrates, and less commonly neuropathy, sinusitis, and cardiomyopathy.
Leukotriene receptor antagonist-associated Churg–Strauss syndrome
Antisynthetase syndrome
Mast cell activation syndrome
Drug reaction with eosinophilia and systemic symptoms
Critical illness–related corticosteroid insufficiency
Jarisch–Herxheimer reaction
Swyer–James syndrome
CREST syndrome